Fig. 3From: Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority studyMean change from baseline in SGRQ Total score over 24 weeks (ITT population)Back to article page